Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Empresa Reclamada
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions leer más
There are some great people working there, but it is ruined by how the company is run by upper management. People don't feel respected or feel that their contributions are appreciated.
¿Qué es lo mejor de tu paquéte de compensación?
The employee stock purchase plan
Revisión
¿Qué va mal y cómo puede mejorarse?
The daily stress and work hours need to be reduced.
Revisión
¿Qué necesita mejorar el equipo directivo?
They need to respect their employees as people and respect their lives and responsibilities outside of work.
Revisión
¿Cómo pueden mejorar tus colegas y que pueden hacer para trabajar mejor juntos?
People do not have time to do a task so there is always conflicts around priorities and people not meeting timelines
Revisión
¿Qué debe cambiar para mejorar la cultura de la empresa?
The expectation of being available 24/7 including holidays leads to quick burnout. There is no respect for the employees and what is being asked of them. Upper management needs to provide more resources and stop pushing the employees to the point of exhaustion and burnout.
Revisión
Other Employee Reviews for Karyopharm Therapeutics
×